Work that began at OMRF in the 1980s gives birth to a life-changing medication When Novartis announced in November that the U.S. Food and Drug Administration had approved the company’s new drug to treat sickle cell anemia, the press release didn’t mention Oklahoma. But it should have. The drug, known as Adakveo, is based […]
Adakveo significantly reduces pain crises in sickle cell patients.
For Mary Long, the answer to her pain may, literally, be right around the corner.